Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
The United Laboratories International Holdings ( (HK:3933) ) has issued an update.
The United Laboratories International Holdings Limited announced the payment of an interim dividend of RMB16 cents per share for the first half of 2025, which will be converted and paid in Hong Kong dollars at a rate of HK$0.175070 per share. This payment is scheduled for 15 October 2025, benefiting shareholders listed as of 30 September 2025, reflecting the company’s commitment to returning value to its shareholders.
The most recent analyst rating on (HK:3933) stock is a Hold with a HK$16.00 price target. To see the full list of analyst forecasts on The United Laboratories International Holdings stock, see the HK:3933 Stock Forecast page.
More about The United Laboratories International Holdings
The United Laboratories International Holdings Limited is a company incorporated in the Cayman Islands, operating in the pharmaceutical industry. It focuses on the production and distribution of pharmaceutical products.
Average Trading Volume: 18,845,767
Technical Sentiment Signal: Buy
Current Market Cap: HK$29.63B
See more data about 3933 stock on TipRanks’ Stock Analysis page.